{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:14:49Z","timestamp":1789676089175,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006701","name":"Umm Al-Qura University","doi-asserted-by":"publisher","award":["26UQU4310387GSSR02"],"award-info":[{"award-number":["26UQU4310387GSSR02"]}],"id":[{"id":"10.13039\/501100006701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cca.2026.121103","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T23:19:29Z","timestamp":1779319169000},"page":"121103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective"],"prefix":"10.1016","volume":"590","author":[{"given":"G.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa Jatti","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalpa R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka Jyothi.","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Shefali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachan","family":"Karmakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumud","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Bhopate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeet Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed Hassan","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121103_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211033103","article-title":"Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment","volume":"12","author":"Shariq","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"issue":"4","key":"10.1016\/j.cca.2026.121103_bb0010","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad170","article-title":"Clinical and pathological predictors of death for adrenocortical carcinoma","volume":"8","author":"Pato","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.cca.2026.121103_bb0015","doi-asserted-by":"crossref","first-page":"1134643","DOI":"10.3389\/fendo.2023.1134643","article-title":"Prognostic predictors of adrenocortical carcinoma: a single-center thirty-year experience","volume":"14","author":"Pan","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.cca.2026.121103_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12672-011-0088-0","article-title":"The Weiss score and beyond \u2013 histopathology for adrenocortical carcinoma","volume":"2","author":"Papotti","year":"2011","journal-title":"Horm Cancer"},{"key":"10.1016\/j.cca.2026.121103_bb0025","article-title":"Was it an adrenocortical adenoma or an adrenocortical carcinoma? Limitation of the Weiss scoring system in determining the malignant potential of adrenocortical tumor: report on two cases","volume":"2022","author":"Wong","year":"2022","journal-title":"Case Rep. Endocrinol."},{"issue":"3","key":"10.1016\/j.cca.2026.121103_bb0030","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae012","article-title":"Incidence, treatment, and survival of adrenocortical carcinoma in Denmark 2003\u20132019","volume":"8","author":"Pedersen","year":"2024","journal-title":"J. Endocr. Soc."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0035","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s12672-025-03649-y","article-title":"Multi-omics-based molecular classification of adrenocortical carcinoma predicts response to immunotherapy and targeted treatments","volume":"16","author":"Jin","year":"2025","journal-title":"Discov. Oncol."},{"issue":"15","key":"10.1016\/j.cca.2026.121103_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153890","article-title":"Mass spectrometry-based proteomic discovery of prognostic biomarkers in adrenal cortical carcinoma","volume":"13","author":"Jang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.cca.2026.121103_bb0045","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1210\/clinem\/dgz141","article-title":"Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma","volume":"105","author":"Chortis","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121103_bb0050","doi-asserted-by":"crossref","first-page":"1258902","DOI":"10.3389\/fmolb.2023.1258902","article-title":"Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers","volume":"10","author":"Martin-Hernandez","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0055","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.cca.2026.121103_bb0060","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock","year":"2020","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121103_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2015.00045","article-title":"Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment","volume":"3","author":"Lib\u00e9","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/ijem.ijem_335_21","article-title":"Adrenal incidentaloma needs thorough biochemical evaluation \u2013 an institutional experience","volume":"26","author":"Shah","year":"2022","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0075","article-title":"Adrenocortical carcinoma with dual androgen and cortisol secretion","volume":"67","author":"Kalfoutzou","year":"2025","journal-title":"Folia Med (Plovdiv)"},{"issue":"3","key":"10.1016\/j.cca.2026.121103_bb0080","article-title":"Small incidental pheochromocytoma presenting with normal or borderline high 24-hour urine fractionated metanephrines","volume":"2","author":"Kwek","year":"2024","journal-title":"JCEM Case Rep."},{"issue":"2","key":"10.1016\/j.cca.2026.121103_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.21037\/gs.2020.03.04","article-title":"Not all adrenal incidentalomas require biochemical testing to exclude pheochromocytoma: Mayo Clinic experience and a meta-analysis","volume":"9","author":"Gruber","year":"2020","journal-title":"Gland Surg."},{"issue":"7","key":"10.1016\/j.cca.2026.121103_bb0090","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1245\/s10434-025-17296-8","article-title":"The landmark series: evaluation and management of adrenal incidentalomas","volume":"32","author":"Owei","year":"2025","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.121103_bb0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24\u00a0hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.cca.2026.121103_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"14","key":"10.1016\/j.cca.2026.121103_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14144829","article-title":"Ki-67 as a predictor of metastasis in adrenocortical carcinoma: artificial intelligence insights from retrospective imaging data","volume":"14","author":"Goulian","year":"2025","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121103_bb0110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00423-010-0698-y","article-title":"Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade","volume":"395","author":"Miller","year":"2010","journal-title":"Langenbeck\u2019s Arch. Surg."},{"key":"10.1016\/j.cca.2026.121103_bb0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/IJGM.S399473","article-title":"Prognostic factors of adrenocortical carcinoma: experience from a regional medical center in eastern China","volume":"16","author":"Li","year":"2023","journal-title":"Int J Gen Med"},{"issue":"6","key":"10.1016\/j.cca.2026.121103_bb0120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.cca.2026.121103_bb0125","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0130","doi-asserted-by":"crossref","first-page":"8610","DOI":"10.1038\/s41598-018-26799-2","article-title":"Comprehensive analysis of CTNNB1 in adrenocortical carcinomas: identification of novel mutations and correlation to survival","volume":"8","author":"Maharjan","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cca.2026.121103_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103617","article-title":"Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival","volume":"9","author":"Sun-Zhang","year":"2024","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.cca.2026.121103_bb0140","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","article-title":"Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival","volume":"27","author":"de Reyni\u00e8s","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.121103_bb0145","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1158\/1078-0432.CCR-08-1067","article-title":"Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling","volume":"15","author":"Giordano","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-11-0806","article-title":"Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients","volume":"166","author":"Fragoso","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"24","key":"10.1016\/j.cca.2026.121103_bb0155","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1158\/1078-0432.CCR-09-1587","article-title":"miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer","volume":"15","author":"Soon","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cca.2026.121103_bb0160","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.surg.2013.06.022","article-title":"MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors","volume":"154","author":"Patel","year":"2013","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.cca.2026.121103_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/ERC-13-0051","article-title":"Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients","volume":"20","author":"Chabre","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2026.121103_bb0170","first-page":"923","article-title":"DNA methylation is an independent prognostic marker of survival in adrenocortical cancer","volume":"102","author":"Jouinot","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.cca.2026.121103_bb0175","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EC-20-0228","article-title":"Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma","volume":"9","author":"Jouinot","year":"2020","journal-title":"Endocr. Connect."},{"issue":"15 Suppl","key":"10.1016\/j.cca.2026.121103_bb0180","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2021.39.15_suppl.4585","article-title":"Circulating tumor DNA (ctDNA) in patients with advanced adrenocortical carcinoma","volume":"39","author":"Nazha","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.cca.2026.121103_bb0185","article-title":"Pre-analytical evaluation of Streck cell-free DNA blood collection tubes for liquid profiling in oncology","volume":"13","author":"Diaz","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cca.2026.121103_bb0190","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.81.EP582","article-title":"A personalised approach to tracking circulating cell free tumour derived DNA in a patient with adrenocortical carcinoma","author":"Gohil","year":"2022","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.cca.2026.121103_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.121103_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.937367","article-title":"Modulation of autophagy in adrenal tumors","volume":"13","author":"Sousa","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2026.121103_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/708036","article-title":"Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity","volume":"2012","author":"Jaggupilli","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/ERC-07-0003","article-title":"Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane","volume":"15","author":"Stigliano","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.cca.2026.121103_bb0215","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.18632\/oncotarget.3299","article-title":"2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma","volume":"6","author":"Poli","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.cca.2026.121103_bb0220","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1021\/acs.jproteome.5c00740","article-title":"Comparative proteomic profiling of adrenocortical neoplasia using mass spectrometry","volume":"24","author":"Kremer","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2026.121103_bb0225","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.110.OC1.3","article-title":"Quantitative proteomics of pediatric adrenocortical tumors reveals a continuum of molecular alterations and identifies prognostically relevant subgroups","author":"Metousis","year":"2025","journal-title":"Endocr. Abstr."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0230","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3803\/EnM.2020.35.1.132","article-title":"Protein expression of cyclin B1, transferrin receptor, and fibronectin is correlated with the prognosis of adrenal cortical carcinoma","volume":"35","author":"Moon","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"11","key":"10.1016\/j.cca.2026.121103_bb0235","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1245\/s10434-014-3768-5","article-title":"Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma","volume":"21","author":"Patel","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.121103_bb0240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12020-019-02033-5","article-title":"IGF2 role in adrenocortical carcinoma biology","volume":"66","author":"Pereira","year":"2019","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.cca.2026.121103_bb0245","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa293","article-title":"Expression of SOAT1 in adrenocortical carcinoma and response to mitotane monotherapy: an ENSAT multicenter study","volume":"105","author":"Weigand","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0250","doi-asserted-by":"crossref","first-page":"2397092","DOI":"10.1080\/07853890.2024.2397092","article-title":"Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy response in pediatric and adult adrenocortical carcinoma","volume":"56","author":"Chen","year":"2024","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.121103_bb0255","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ejendo\/lvaf226","article-title":"Agouti-related peptide: a promising prognostic biomarker in adrenocortical carcinoma. Results from a large single-Centre cross-sectional analysis","volume":"193","author":"Detomas","year":"2025","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.cca.2026.121103_bb0260","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/14789450.2016.1210008","article-title":"Proteome analysis of adrenal cortical tumors","volume":"13","author":"Kim","year":"2016","journal-title":"Expert Rev. Proteomics"},{"issue":"12","key":"10.1016\/j.cca.2026.121103_bb0265","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121103_bb0270","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.41.OC1.4","article-title":"Urine steroid metabolomics is a highly sensitive tool for post-operative recurrence detection in adrenocortical carcinoma","author":"Chortis","year":"2016","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.cca.2026.121103_bb0275","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.81.P386","article-title":"Urinary steroid metabolomics for adrenocortical cancer diagnosis: comparison of gas chromatography mass spectrometry to liquid chromatography mass spectrometry","author":"Taylor","year":"2022","journal-title":"Endocr. Abstr."},{"issue":"9","key":"10.1016\/j.cca.2026.121103_bb0280","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.cca.2026.121103_bb0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-18-0782","article-title":"Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma","volume":"180","author":"Schweitzer","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121103_bb0290","doi-asserted-by":"crossref","first-page":"1435102","DOI":"10.3389\/fendo.2024.1435102","article-title":"Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma","volume":"15","author":"Weng","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.cca.2026.121103_bb0295","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1210\/clinem\/dgae604","article-title":"Serum steroid profiling in the diagnosis of adrenocortical carcinoma: a prospective cohort study","volume":"110","author":"Yu","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121103_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2026.106937","article-title":"Serum steroid profiling by LC-MS\/MS in distinguishing adrenocortical carcinoma from other indeterminate adrenal masses","volume":"258","author":"Rao","year":"2026","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14010020","article-title":"Early detection of recurrence and progress using serum steroid profiling by LC-MS\/MS in patients with adrenocortical carcinoma","volume":"14","author":"Kimpel","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0310","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12902-020-00652-y","article-title":"Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma","volume":"20","author":"Suzuki","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2026.121103_bb0315","article-title":"OR32-07 integrated liquid biopsy by ccfDNA and urinary steroid metabolomics for longitudinal monitoring of adrenocortical carcinoma","volume":"9","author":"Tourigny","year":"2025","journal-title":"J. Endocr. Soc."},{"issue":"5","key":"10.1016\/j.cca.2026.121103_bb0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/ERC-13-0232","article-title":"Metabolomic profile of the adrenal gland: from physiology to pathological conditions","volume":"20","author":"Imperiale","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"issue":"66","key":"10.1016\/j.cca.2026.121103_bb0325","doi-asserted-by":"crossref","first-page":"109924","DOI":"10.18632\/oncotarget.18968","article-title":"Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches","volume":"8","author":"Hescot","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.cca.2026.121103_bb0330","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac102","article-title":"Mitotane targets lipid droplets to induce lipolysis in adrenocortical carcinoma","volume":"163","author":"Warde","year":"2022","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.surg.2021.04.049","article-title":"Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics","volume":"171","author":"Subramanian","year":"2022","journal-title":"Surgery"},{"issue":"16","key":"10.1016\/j.cca.2026.121103_bb0340","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167007","article-title":"Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes","volume":"8","author":"Wang","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.cca.2026.121103_bb0345","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.109.OC2.3","article-title":"Serum untargeted metabolomics reveals widespread metabolic dysregulation in adrenocortical carcinoma","author":"Chortis","year":"2025","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.cca.2026.121103_bb0350","article-title":"Evaluation of adrenal tumors and analysis of the metabolic profile of patients with incidentaloma","volume":"51","author":"Montalv\u00e3o","year":"2025","journal-title":"Rev. Col. Bras. Cir."},{"issue":"23","key":"10.1016\/j.cca.2026.121103_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233784","article-title":"Molecular cluster mining of adrenocortical carcinoma via multi-omics data analysis aids precise clinical therapy","volume":"11","author":"Guan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.121103_bb0360","doi-asserted-by":"crossref","first-page":"1258902","DOI":"10.3389\/fmolb.2023.1258902","article-title":"Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers","volume":"10","author":"Martin-Hernandez","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0365","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41698-025-01092-4","article-title":"Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment","volume":"9","author":"Hao","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0370","doi-asserted-by":"crossref","first-page":"8860","DOI":"10.1038\/s41467-025-63912-2","article-title":"Impact of steroid differentiation on tumor microenvironment revealed by single-nucleus atlas of adrenal tumors","volume":"16","author":"Jouinot","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cca.2026.121103_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4776","article-title":"A simplified method for therapeutic drug monitoring of mitotane by gas chromatography-electron ionization-mass spectrometry","volume":"34","author":"Ando","year":"2020","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.cca.2026.121103_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/jcrpe.v2i1.1","article-title":"Steroid assays in paediatric endocrinology","volume":"2","author":"Honour","year":"2010","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.cca.2026.121103_bb0385","article-title":"Effects of in vitro hemolysis and repeated freeze-thaw cycles in protein abundance quantification using the SomaScan and Olink assays","author":"Candia","year":"2025","journal-title":"bioRxiv"},{"issue":"1\u20132","key":"10.1016\/j.cca.2026.121103_bb0390","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mce.2012.12.026","article-title":"Mass spectrometry theory and application to adrenal diseases","volume":"371","author":"Wooding","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3\u20135","key":"10.1016\/j.cca.2026.121103_bb0395","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsbmb.2011.12.001","article-title":"Standardized LC-MS\/MS based steroid hormone profile-analysis","volume":"129","author":"Koal","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.cca.2026.121103_bb0400","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1515\/cclm-2024-0550","article-title":"A global perspective on the status of clinical metabolomics in laboratory medicine \u2013 a survey by the IFCC metabolomics working group","volume":"62","author":"Fux","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2026.121103_bb0405","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12672-011-0099-x","article-title":"Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseases","volume":"2","author":"McDonald","year":"2011","journal-title":"Horm Cancer"},{"issue":"13\u201314","key":"10.1016\/j.cca.2026.121103_bb0410","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.clinbiochem.2016.04.009","article-title":"LC-MS\/MS analysis of steroids in the clinical laboratory","volume":"49","author":"Keevil","year":"2016","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121103_bb0415","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.110.P10","article-title":"Validation of prognostic biomarkers in adrenocortical carcinoma through next-generation sequencing in real-life setting","author":"Mohamed","year":"2025","journal-title":"Endocr. Abstr."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2026.121103_bb0420","article-title":"OR32-07 integrated liquid biopsy by ccfDNA and urinary steroid metabolomics for longitudinal monitoring of adrenocortical carcinoma","volume":"9","author":"Tourigny","year":"2025","journal-title":"J. Endocr. Soc."}],"updated-by":[{"DOI":"10.1016\/j.cca.2026.121150","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000}},{"DOI":"10.1016\/j.cca.2026.121150","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000}}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:12:26Z","timestamp":1786014746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":84,"alternative-id":["S0009898126002858"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121103","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121103"}}